Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT01011426 | Bisacodyl Use in the Post-operative Care of Obstetrical/Gynecological (OB/GYN) Patients | PHASE2 | COMPLETED | 285 | — | — | Apr 1, 2009 | Jun 1, 2012 | Jan 19, 2014 | - | — |
| Name | Type | Description |
|---|---|---|
| Bisacodyl | DRUG | 5mg po 6 hours postoperatively, repeat in 12 hours if no flatus |
| placebo | DRUG | 1 capsule po 6 hours after surgery; repeat in 12 hours if no flatus |